Nevado Julián, Tenbaum Stephan P, Aranda Ana
Unidad de Investigación, Hospital Universitario de Getafe, 28905 Getafe, Madrid, Spain.
Mol Cell Endocrinol. 2004 Jul 30;222(1-2):41-51. doi: 10.1016/j.mce.2004.05.003.
Nuclear hormone receptors interact with the basal-transcriptional complex and/or coactivators to regulate transcriptional activation. These activator-target interactions recruit the transcriptional machinery to the promoter and may also stimulate transcriptional events subsequent to the binding of the machinery to the promoter or enhancer element. We describe a novel functional interaction of the nuclear thyroid receptor (TR), with a human Mediator component (hSrb7), and a human TFIIH component (hMo15). In mammalian two-hybrid experiments as well as in GST-pull down assays, hSrb7 interacts with TR but not with other nuclear receptors such as the retinoic acid receptor (RAR) or the vitamin D receptor (VDR). Whereas hMo15 also interacts with VDR and RAR in mammalian two-hybrid assays, no association of hSrb7 with VDR or RAR is found. Accordingly, cotransfection of TR and hSrb7 increases thyroid hormone (T3)-dependent transcription in an AF-2-dependent manner, while hSrb7 causes no stimulation of vitamin D- or retinoic acid-mediated transactivation. These results reveal a novel co-activator role for hSrb7 and hMo15 on TR transcriptional responses, and demonstrate that different receptors can selectively target different co-activators or general transcription factors to stimulate transcription.
核激素受体与基础转录复合物和/或共激活因子相互作用以调节转录激活。这些激活剂-靶标相互作用将转录机制招募到启动子上,并且还可能刺激转录机制与启动子或增强子元件结合后发生的转录事件。我们描述了核甲状腺受体(TR)与人类中介体成分(hSrb7)和人类TFIIH成分(hMo15)之间的一种新型功能相互作用。在哺乳动物双杂交实验以及GST下拉实验中,hSrb7与TR相互作用,但不与其他核受体如视黄酸受体(RAR)或维生素D受体(VDR)相互作用。而在哺乳动物双杂交实验中hMo15也与VDR和RAR相互作用,但未发现hSrb7与VDR或RAR有联系。因此,TR和hSrb7的共转染以AF-2依赖的方式增加甲状腺激素(T3)依赖性转录,而hSrb7不会刺激维生素D或视黄酸介导的反式激活。这些结果揭示了hSrb7和hMo15在TR转录反应中的一种新型共激活因子作用,并证明不同的受体可以选择性地靶向不同的共激活因子或一般转录因子以刺激转录。